VEEV241220C185000
- 49.85
- 0.000.00%
Veeva Systems Newsroom
Truist Financial Keeps Their Hold Rating on Veeva Systems (VEEV)
Truist Financial Maintains Veeva Systems(VEEV.US) With Hold Rating, Maintains Target Price $261
Veeva Systems Analyst Ratings
Mizuho Securities Maintains Veeva Systems(VEEV.US) With Buy Rating, Announces Target Price $280
Citi Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $307
A Quick Look at Today's Ratings for Veeva Systems(VEEV.US), With a Forecast Between $183 to $300
Veeva Systems Is Maintained at Neutral by B of A Securities
KeyBanc Raises Veeva Systems Price Target to $285 From $240, Maintains Overweight Rating
Stifel Maintains Buy on Veeva Systems, Raises Price Target to $272
A Quick Look at Today's Ratings for Veeva Systems(VEEV.US), With a Forecast Between $183 to $290
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Monte Rosa Therapeutics (GLUE) and CAMP4 Therapeutics Corporation (CAMP)
Veeva Systems (VEEV) Gets a Buy From RBC Capital
Veeva Systems: Strong Market Position and Promising Growth Trajectory Justify Buy Rating
Veeva Systems Is Maintained at Overweight by Piper Sandler
Veeva Systems Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Veeva Systems (VEEV) and Cooper Co (COO)
Veeva Systems Analyst Ratings
Truist Financial Maintains Veeva Systems(VEEV.US) With Hold Rating
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $173
Truist Financial Sticks to Its Hold Rating for Veeva Systems (VEEV)